(3b,6a,12b,17a,20S)-Dammar-24-ene-3,6,12,17,20-pentol 20-[glucosyl-(1->2)-glucoside] 6-xyloside
Internal ID | 8f1f629b-e335-41b3-a1ed-d6ee5aabf04a |
Taxonomy | Lipids and lipid-like molecules > Prenol lipids > Triterpenoids |
IUPAC Name | 2-[4,5-dihydroxy-6-(hydroxymethyl)-2-[6-methyl-2-[3,12,17-trihydroxy-4,4,8,10,14-pentamethyl-6-(3,4,5-trihydroxyoxan-2-yl)oxy-1,2,3,5,6,7,9,11,12,13,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
SMILES (Canonical) | CC(=CCCC(C)(C1(CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(CO5)O)O)O)C)O)C)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)C |
SMILES (Isomeric) | CC(=CCCC(C)(C1(CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(CO5)O)O)O)C)O)C)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)CO)O)O)O)C |
InChI | InChI=1S/C47H80O19/c1-21(2)10-9-12-46(8,66-41-36(33(57)31(55)26(19-49)64-41)65-40-35(59)32(56)30(54)25(18-48)63-40)47(60)15-14-44(6)37(47)22(50)16-27-43(5)13-11-28(52)42(3,4)38(43)24(17-45(27,44)7)62-39-34(58)29(53)23(51)20-61-39/h10,22-41,48-60H,9,11-20H2,1-8H3 |
InChI Key | CXXVAICRCFBOHJ-UHFFFAOYSA-N |
Popularity | 4 references in papers |
Molecular Formula | C47H80O19 |
Molecular Weight | 949.10 g/mol |
Exact Mass | 948.52938032 g/mol |
Topological Polar Surface Area (TPSA) | 318.00 Ų |
XlogP | -0.10 |
Atomic LogP (AlogP) | -1.30 |
H-Bond Acceptor | 19 |
H-Bond Donor | 13 |
Rotatable Bonds | 12 |
There are no found synonyms. |
![2D Structure of (3b,6a,12b,17a,20S)-Dammar-24-ene-3,6,12,17,20-pentol 20-[glucosyl-(1->2)-glucoside] 6-xyloside 2D Structure of (3b,6a,12b,17a,20S)-Dammar-24-ene-3,6,12,17,20-pentol 20-[glucosyl-(1->2)-glucoside] 6-xyloside](https://plantaedb.com/storage/docs/compounds/2023/11/3b6a12b17a20s-dammar-24-ene-36121720-pentol-20-glucosyl-1-2-glucoside-6-xyloside.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.6877 | 68.77% |
Caco-2 | - | 0.8884 | 88.84% |
Blood Brain Barrier | - | 0.5500 | 55.00% |
Human oral bioavailability | - | 0.8000 | 80.00% |
Subcellular localzation | Mitochondria | 0.7251 | 72.51% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.8397 | 83.97% |
OATP1B3 inhibitior | + | 0.8189 | 81.89% |
MATE1 inhibitior | - | 0.9800 | 98.00% |
OCT2 inhibitior | - | 0.6000 | 60.00% |
BSEP inhibitior | - | 0.5000 | 50.00% |
P-glycoprotein inhibitior | + | 0.7616 | 76.16% |
P-glycoprotein substrate | + | 0.5127 | 51.27% |
CYP3A4 substrate | + | 0.7405 | 74.05% |
CYP2C9 substrate | - | 0.7890 | 78.90% |
CYP2D6 substrate | - | 0.8406 | 84.06% |
CYP3A4 inhibition | - | 0.9502 | 95.02% |
CYP2C9 inhibition | - | 0.8671 | 86.71% |
CYP2C19 inhibition | - | 0.9036 | 90.36% |
CYP2D6 inhibition | - | 0.9380 | 93.80% |
CYP1A2 inhibition | - | 0.9057 | 90.57% |
CYP2C8 inhibition | + | 0.6725 | 67.25% |
CYP inhibitory promiscuity | - | 0.9413 | 94.13% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.9900 | 99.00% |
Carcinogenicity (trinary) | Non-required | 0.6474 | 64.74% |
Eye corrosion | - | 0.9907 | 99.07% |
Eye irritation | - | 0.9053 | 90.53% |
Skin irritation | - | 0.5956 | 59.56% |
Skin corrosion | - | 0.9488 | 94.88% |
Ames mutagenesis | - | 0.6200 | 62.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8021 | 80.21% |
Micronuclear | - | 0.8800 | 88.00% |
Hepatotoxicity | + | 0.5201 | 52.01% |
skin sensitisation | - | 0.8991 | 89.91% |
Respiratory toxicity | + | 0.5444 | 54.44% |
Reproductive toxicity | + | 0.8889 | 88.89% |
Mitochondrial toxicity | - | 0.5875 | 58.75% |
Nephrotoxicity | - | 0.7171 | 71.71% |
Acute Oral Toxicity (c) | I | 0.5677 | 56.77% |
Estrogen receptor binding | + | 0.7544 | 75.44% |
Androgen receptor binding | + | 0.7405 | 74.05% |
Thyroid receptor binding | - | 0.5153 | 51.53% |
Glucocorticoid receptor binding | + | 0.6308 | 63.08% |
Aromatase binding | + | 0.6611 | 66.11% |
PPAR gamma | + | 0.7727 | 77.27% |
Honey bee toxicity | - | 0.5886 | 58.86% |
Biodegradation | - | 0.7250 | 72.50% |
Crustacea aquatic toxicity | - | 0.5200 | 52.00% |
Fish aquatic toxicity | + | 0.9172 | 91.72% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.70% | 91.11% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.61% | 97.25% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 96.43% | 95.93% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.65% | 97.09% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 90.50% | 95.58% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 90.40% | 95.50% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.61% | 94.45% |
CHEMBL1937 | Q92769 | Histone deacetylase 2 | 88.98% | 94.75% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 88.97% | 95.00% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 88.72% | 100.00% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 87.82% | 97.28% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 87.36% | 96.09% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.20% | 95.89% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 87.19% | 92.94% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 87.05% | 91.03% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 86.83% | 96.61% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 86.67% | 95.38% |
CHEMBL3524 | P56524 | Histone deacetylase 4 | 86.39% | 92.97% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 85.97% | 97.79% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 85.53% | 92.88% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 85.32% | 100.00% |
CHEMBL4105786 | P41182 | B-cell lymphoma 6 protein | 85.18% | 92.86% |
CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 85.05% | 90.24% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 84.72% | 100.00% |
CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 84.41% | 91.24% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 84.37% | 96.90% |
CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 84.05% | 95.83% |
CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 82.84% | 92.50% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 82.58% | 97.14% |
CHEMBL2581 | P07339 | Cathepsin D | 82.38% | 98.95% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 82.32% | 86.33% |
CHEMBL279 | P35968 | Vascular endothelial growth factor receptor 2 | 82.28% | 95.52% |
CHEMBL4581 | P52732 | Kinesin-like protein 1 | 82.03% | 93.18% |
CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 81.49% | 97.86% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 81.25% | 90.08% |
CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 81.22% | 97.33% |
CHEMBL5524 | Q99873 | Protein-arginine N-methyltransferase 1 | 80.50% | 96.67% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 80.41% | 97.50% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 80.33% | 82.50% |
CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 80.26% | 91.07% |
CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 80.14% | 98.57% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Cyclanthera pedata |
PubChem | 131751719 |
LOTUS | LTS0223013 |
wikiData | Q104972182 |